About the Editors

Chief Editor: Vesna Todorović, PhD, Springer Nature, Berlin, Germany

Vesna joined the Nature Portfolio in 2014 as an editor for Nature Communications, handling an array of topics in development, disease, physiology and bioengineering. In 2017 she transferred to Nature, where she became responsible for content on cardiovascular biology and metabolism. She became the launch Chief Editor of Nature Cardiovascular Research in 2021. She holds a PhD in molecular biology from the University of Belgrade, Serbia, and the International Centre for Genetic Engineering and Biotechnology in Trieste, Italy, and was a research scientist at NYU Langone School of Medicine and Icahn School of Medicine at Mount Sinai in New York, where she investigated cardiovascular development and disease. Vesna is based in the Berlin office.


Senior Editor: Michelle Korda, PhD, Springer Nature, London, United Kingdom

Michelle managed advanced therapy clinical trials at University College London (UCL) and ran a stratified medicine consortium and clinical trial for the treatment of rheumatoid arthritis at Queen Mary University of London. Her expertise encompasses advanced-therapy clinical trials and in vivo and in vitro models for bone-defect healing. Michelle obtained a PhD in biomedical engineering from UCL in 2007, focusing on stem cells’ regenerative capabilities around revision hip implants. Michelle started her editorial career at Nature Biomedical Engineering as part of its launching team in May 2016. In her role, she managed a broad spectrum of submissions, with a focus on medical devices and tissue engineering. Michelle brings a wealth of experience and an understanding of cutting-edge biomedical research to her role. Michelle joined the Research Cross-Journal Editorial team in January 2024.


Associate Editor: Elisa Martini, PhD, Springer Nature, Milan, Italy

Elisa received her PhD from the Open University and Humanitas Research Hospital in Milan, Italy, under the supervision of Dr Marinos Kallikourdis and in collaboration with Prof Gianluigi Condorelli, investigating the adaptive immune response in pathological cardiac hypertrophy, heart failure, and atherosclerosis. As a postdoctoral fellow, Elisa continued her work with Dr. Kallikourdis investigating the inflammatory response and T cell activation in heart failure via single-cell sequencing and then moved to Prof. Chiara Bonini’s laboratory to develop a Treg Adoptive Cell Therapy for autoimmune disease. Elisa joined the team in February 2023 and is based in the Milan office.


Associate Editor: Gerburg Schwaerzer, PhD, Springer Nature, Berlin, Germany

Gerburg received her PhD from the Institute of Chemistry and Biochemistry, Free University of Berlin, Germany, where she investigated drugs for cartilage and bone repair. During her postdoctoral studies at the University of California San Diego, she switched focus from the skeletal to the cardiovascular system, investigating the function of protein kinase G in vessel wall integrity, aortic aneurysms, cardiomyopathy, and diabetes. Upon her return to Germany, she continued to pursue her interest in vessel biology, by studying the mechanisms causing renal dysfunctions and hypertension at the Christian-Albrechts-University Kiel, and later on, the molecular mechanisms causing obesity-associated inflammation and cardiovascular diseases at the University Hospital in Bonn, Germany. Gerburg is based in the Berlin office.


Associate Editor: Andrea Tavosanis, PhD, Springer Nature, Milan, Italy

Andrea received his PhD from the Barts Cancer Institute, Queen Mary University of London, under the supervision of Dr. Kamil Kranc, investigating the role of mRNA post-transcriptional regulators in normal and malignant haematopoiesis. Following his PhD, Andrea joined the research group led by Dr. Andrea Ditadi at S.Raffaele Hospital / TIGET in Milan, where he studied haematopoietic development during different stages of embryogenesis. Andrea joined the journal in January 2024 and is based in the Milan office.


The Research Cross-Journal Editorial Team supports the Nature-branded research journals, with a focus on handling primary research manuscripts. 

The Reviews Cross-Journal Editorial Team handles Research Briefing articles for the Nature-branded research journals.